The present invention provides pyrroloquinolinyl pyrrole 2 5 dione formulations and methods of treating a cell proliferative disorder such as a cancer by administering to a subject in need thereof a therapeutically effective amount of the formulations containing pyrroloquinolinyl pyrrole 2 5 dione compounds.